DRTS — Alpha Tau Medical Ltd. Dilution Risk Tracker

Alpha Tau Medical Ltd. (DRTS) has a DilutionScore of 37/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

The most significant dilution vector for DRTS is its shelf registration capacity of $300.0M. A shelf registration (typically an S-3 filing) gives a company pre-approved access to raise capital quickly without a traditional roadshow. The registered amount represents the maximum that can be raised — not necessarily what will be raised — but active shelves combined with tight cash positions are the pattern DilutionWatch monitors most closely. DilutionWatch tracks 15.9M outstanding warrants for DRTS. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window.

DilutionWatch tracks over 25 SEC filing types for DRTS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for DRTS alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.